Elevated homocysteine is associated with increased rates of epigenetic aging in a population with mild cognitive impairment

Elevated homocysteine is associated with increased rates of epigenetic aging in a population with mild cognitive impairment

Elevated plasma total homocysteine (tHcy) is associated with the development of Alzheimer's disease and other forms of dementia. In this study, we report the relationship between tHcy and epigenetic age in older adults with mild cognitive impairment from the VITACOG study. Epigenetic age and ra...

ver descrição completa

Detalhes bibliográficos
Main Authors:	Holmes, HE, Valentin, RE, Jernerén, F, de Jager Loots, CA, Refsum, H, Smith, AD, Guarente, L, Dellinger, RW, Sampson, D, Alzheimer's Disease Neuroimaging Initiative
Formato:	Journal article
Idioma:	English
Publicado em:	Wiley Open Access 2024

Registos relacionados

Early diagnosis of Alzheimer’s disease and mild cognitive impairment using MRI analysis and machine learning algorithms
Por: Helia Givian, et al.
Publicado em: (2024-12-01)

NeuropsychBrainAge: A biomarker for conversion from mild cognitive impairment to Alzheimer's disease
Por: Jorge Garcia Condado, et al.
Publicado em: (2023-10-01)

Omega-3 Fatty Acid Status Enhances the Prevention of Cognitive Decline by B Vitamins in Mild Cognitive Impairment
Por: Oulhaj, A, et al.
Publicado em: (2016)

Choroid plexus volumes and auditory verbal learning scores are associated with conversion from mild cognitive impairment to Alzheimer's disease
Por: Michael J. Pearson, et al.
Publicado em: (2024-07-01)

Serotonin enhances neurogenesis biomarkers, hippocampal volumes, and cognitive functions in Alzheimer’s disease
Por: Ali Azargoonjahromi, et al.
Publicado em: (2024-12-01)

Sleep and nighttime behavior disorders in older adults: associations with hypercholesterolemia and hypertriglyceridemia at baseline, and a predictive analysis of incident cases at 12 months follow-up
Por: Asma Hallab, et al.
Publicado em: (2024-09-01)

Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial.
Por: de Jager, C, et al.
Publicado em: (2012)

Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: A randomized controlled trial
Por: De Jager, C, et al.
Publicado em: (2012)

Alteration in temporal-cerebellar effective connectivity can effectively distinguish stable and progressive mild cognitive impairment
Por: Chen Xue, et al.
Publicado em: (2024-08-01)

Episodic memory network characteristics in patients with amnestic mild cognitive impairment accompanied by executive function impairment
Por: Chao Wang, et al.
Publicado em: (2024-06-01)

Detection of Alzheimer’s Disease Using Hybrid Meta-ROI of MRI Structural Images
Por: Xiaoming Zheng, et al.
Publicado em: (2024-10-01)

Use of Deep-Learning Genomics to Discriminate Healthy Individuals from Those with Alzheimer’s Disease or Mild Cognitive Impairment
Por: Lanlan Li, et al.
Publicado em: (2021-01-01)

Predicting the Conversion from Mild Cognitive Impairment to Alzheimer’s Disease Using an Explainable AI Approach
Por: Gerasimos Grammenos, et al.
Publicado em: (2024-04-01)

Definition and analysis of gray matter atrophy subtypes in mild cognitive impairment based on data-driven methods
Por: Baiwen Zhang, et al.
Publicado em: (2024-06-01)

Explainability of three-dimensional convolutional neural networks for functional magnetic resonance imaging of Alzheimer's disease classification based on gradient-weighted class activation mapping.
Por: Boyue Song, et al.
Publicado em: (2024-01-01)

Imputation-Based Variable Selection Method for Block-Wise Missing Data When Integrating Multiple Longitudinal Studies
Por: Zhongzhe Ouyang, et al.
Publicado em: (2024-03-01)

Sex-dependent association of serum uric acid levels with amyloid accumulation among amyloid-positive older adults.
Por: Guanan Zhao, et al.
Publicado em: (2024-01-01)

Elevated homocysteine and N-methyl-d-aspartate-receptor antibodies as a cause of behavioural and cognitive decline in 22q11.2 deletion syndrome.
Por: Jones, S, et al.
Publicado em: (2017)

Two for tau: automated model discovery reveals two-stage tau aggregation dynamics in Alzheimer’s disease
Por: Stockman, CA, et al.
Publicado em: (2024)

Longitudinal accelerated brain age in mild cognitive impairment and Alzheimer’s disease
Por: Maria Ly, et al.
Publicado em: (2024-10-01)

Associations of Serum Isoleucine with Mild Cognitive Impairment and Alzheimer’s Disease
Por: Xiao-jun Jing, et al.
Publicado em: (2024-09-01)

Sex Differences in Conversion Risk from Mild Cognitive Impairment to Alzheimer’s Disease: An Explainable Machine Learning Study with Random Survival Forests and SHAP
Por: Alessia Sarica, et al.
Publicado em: (2024-02-01)

Random forest prediction of Alzheimer's disease using pairwise selection from time series data
Por: Moore, P, et al.
Publicado em: (2019)

Classification of Alzheimer’s and MCI Patients from Semantically Parcelled PET Images: A Comparison between AV45 and FDG-PET
Por: Seyed Hossein Nozadi, et al.
Publicado em: (2018-01-01)

Brain age gap estimation using attention-based ResNet method for Alzheimer’s disease detection
Por: Atefe Aghaei, et al.
Publicado em: (2024-06-01)

Homocysteine, B vitamins, and cognitive impairment
Por: Smith, A, et al.
Publicado em: (2016)

Homocysteine, B vitamins, and cardiovascular disease
Por: Refsum, H, et al.
Publicado em: (2006)

Homocysteine, B vitamins, and cardiovascular disease.
Por: Refsum, H, et al.
Publicado em: (2006)

Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial
Por: Smith, A, et al.
Publicado em: (2010)

Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial.
Por: Smith, A, et al.
Publicado em: (2010)

Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial.
Por: Smith, A, et al.
Publicado em: (2010)

Learning semi-supervised enrichment of longitudinal imaging-genetic data for improved prediction of cognitive decline
Por: Hoon Seo, et al.
Publicado em: (2024-05-01)

Disrupted single-subject gray matter networks are associated with cognitive decline and cortical atrophy in Alzheimer’s disease
Por: Yaqiong Xiao, et al.
Publicado em: (2024-05-01)

Multiple phenotype association tests based on sliced inverse regression
Por: Wenyuan Sun, et al.
Publicado em: (2024-04-01)

Plasma total homocysteine and memory in the elderly: the Hordaland Homocysteine Study.
Por: Nurk, E, et al.
Publicado em: (2005)

Quantifying uncertainty in brain-predicted age using scalar-on-image quantile regression
Por: Palma, M, et al.
Publicado em: (2020)

Impact of APOE-ε alleles on brain structure and cognitive function in healthy older adults: A VBM and DTI replication study.
Por: Colleen Lacey, et al.
Publicado em: (2024-01-01)

The Association among Hypothalamic Subnits, Gonadotropic and Sex Hormone Plasmas Levels in Alzheimer’s Disease
Por: Edward Ofori, et al.
Publicado em: (2024-03-01)

Uptake of 18F-AV45 in the Putamen Provides Additional Insights into Alzheimer’s Disease beyond the Cortex
Por: Zhengshi Yang, et al.
Publicado em: (2024-01-01)

Polygenic Score for Conscientiousness Is a Protective Factor for Reversion from Mild Cognitive Impairment to Normal Cognition
Por: Xuan Yang, et al.
Publicado em: (2024-08-01)